IBDEI1J0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25507,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,25507,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,25507,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,25508,0)
 ;;=R63.4^^124^1247^148
 ;;^UTILITY(U,$J,358.3,25508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25508,1,3,0)
 ;;=3^Weight Loss
 ;;^UTILITY(U,$J,358.3,25508,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,25508,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,25509,0)
 ;;=N39.0^^124^1247^144
 ;;^UTILITY(U,$J,358.3,25509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25509,1,3,0)
 ;;=3^UTI
 ;;^UTILITY(U,$J,358.3,25509,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,25509,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,25510,0)
 ;;=N30.90^^124^1247^26
 ;;^UTILITY(U,$J,358.3,25510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25510,1,3,0)
 ;;=3^Cystitis w/o hematuria
 ;;^UTILITY(U,$J,358.3,25510,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,25510,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,25511,0)
 ;;=N76.0^^124^1247^146
 ;;^UTILITY(U,$J,358.3,25511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25511,1,3,0)
 ;;=3^Vaginitis, Unspecified cause, acute
 ;;^UTILITY(U,$J,358.3,25511,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,25511,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,25512,0)
 ;;=N76.3^^124^1247^129
 ;;^UTILITY(U,$J,358.3,25512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25512,1,3,0)
 ;;=3^Subacute and chronic vulvitis
 ;;^UTILITY(U,$J,358.3,25512,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,25512,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,25513,0)
 ;;=N76.1^^124^1247^128
 ;;^UTILITY(U,$J,358.3,25513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25513,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,25513,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,25513,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,25514,0)
 ;;=B97.89^^124^1247^147
 ;;^UTILITY(U,$J,358.3,25514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25514,1,3,0)
 ;;=3^Viral syndrome
 ;;^UTILITY(U,$J,358.3,25514,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,25514,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,25515,0)
 ;;=Z72.51^^124^1247^46
 ;;^UTILITY(U,$J,358.3,25515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25515,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,25515,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,25515,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,25516,0)
 ;;=B16.9^^124^1247^36
 ;;^UTILITY(U,$J,358.3,25516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25516,1,3,0)
 ;;=3^Hepatitis B, acute
 ;;^UTILITY(U,$J,358.3,25516,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,25516,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,25517,0)
 ;;=B18.1^^124^1247^37
 ;;^UTILITY(U,$J,358.3,25517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25517,1,3,0)
 ;;=3^Hepatitis B, chronic without coma
 ;;^UTILITY(U,$J,358.3,25517,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,25517,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,25518,0)
 ;;=B17.10^^124^1247^39
 ;;^UTILITY(U,$J,358.3,25518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25518,1,3,0)
 ;;=3^Hepatitis C, acute
 ;;^UTILITY(U,$J,358.3,25518,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,25518,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,25519,0)
 ;;=B18.2^^124^1247^40
 ;;^UTILITY(U,$J,358.3,25519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25519,1,3,0)
 ;;=3^Hepatitis C, chronic without coma
 ;;^UTILITY(U,$J,358.3,25519,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,25519,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,25520,0)
 ;;=J11.1^^124^1247^54
 ;;^UTILITY(U,$J,358.3,25520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25520,1,3,0)
 ;;=3^Influenza
 ;;^UTILITY(U,$J,358.3,25520,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,25520,2)
 ;;=^5008158
